» Articles » PMID: 19864527

Ductal Carcinoma in Situ: X-ray Fluorescence Microscopy and Dynamic Contrast-enhanced MR Imaging Reveals Gadolinium Uptake Within Neoplastic Mammary Ducts in a Murine Model

Overview
Journal Radiology
Specialty Radiology
Date 2009 Oct 30
PMID 19864527
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To combine dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging with x-ray fluorescence microscopy (XFM) of mammary gland tissue samples from mice to identify the spatial distribution of gadolinium after intravenous injection.

Materials And Methods: C3(1) Sv-40 large T antigen transgenic mice (n = 23) were studied with institutional animal care and use committee approval. Twelve mice underwent DCE MR imaging after injection of gadodiamide, and gadolinium concentration-time curves were fit to a two-compartment pharmacokinetic model with the following parameters: transfer constant (K(trans)) and volume of extravascular extracellular space per unit volume of tissue (v(e)). Eleven mice received gadodiamide before XFM. These mice were sacrificed 2 minutes after injection, and frozen slices containing ducts distended with murine ductal carcinoma in situ (DCIS) were prepared for XFM. One mouse received saline and served as the control animal. Elemental gadolinium concentrations were measured in and around the ducts with DCIS. Hematoxylin-eosin-stained slices of mammary tissues were obtained after DCE MR imaging and XFM.

Results: Ducts containing DCIS were unambiguously identified on MR images. DCE MR imaging revealed gadolinium uptake along the length of ducts with DCIS, with an average K(trans) of 0.21 min(-1) +/- 0.14 (standard deviation) and an average v(e) of 0.40 +/- 0.16. XFM revealed gadolinium uptake inside ducts with DCIS, with an average concentration of 0.475 mmol/L +/- 0.380; the corresponding value for DCE MR imaging was 0.30 mmol/L +/- 0.13.

Conclusion: These results provide insight into the physiologic basis of contrast enhancement of DCIS lesions on DCE MR images: Gadolinium penetrates and collects inside neoplastic ducts.

Citing Articles

Proof of principle study: synchrotron X-ray fluorescence microscopy for identification of previously radioactive microparticles and elemental mapping of FFPE tissues.

Copeland-Hardin L, Paunesku T, Murley J, Crentsil J, Antipova O, Li L Sci Rep. 2023; 13(1):7806.

PMID: 37179410 PMC: 10183016. DOI: 10.1038/s41598-023-34890-6.


Ductal Carcinoma in Situ: State-of-the-Art Review.

Grimm L, Rahbar H, Abdelmalak M, Hall A, Ryser M Radiology. 2021; 302(2):246-255.

PMID: 34931856 PMC: 8805655. DOI: 10.1148/radiol.211839.


Use of X-Ray Fluorescence Microscopy for Studies on Research Models of Hepatocellular Carcinoma.

Paunesku T, Gordon A, White S, Harris K, Antipova O, Maxey E Front Public Health. 2021; 9:711506.

PMID: 34490194 PMC: 8417723. DOI: 10.3389/fpubh.2021.711506.


Paramagnetic MnFe--Polystyrene Nanobeads as a Potential T-T Multimodal Magnetic Resonance Imaging Contrast Agent with Studies.

Dahanayake V, Lyons T, Kerwin B, Rodriguez O, Albanese C, Parasido E ACS Appl Mater Interfaces. 2021; 13(33):39042-39054.

PMID: 34375073 PMC: 10506655. DOI: 10.1021/acsami.1c09232.


Contrast-enhanced mammography: past, present, and future.

Sogani J, Mango V, Keating D, Sung J, Jochelson M Clin Imaging. 2020; 69:269-279.

PMID: 33032103 PMC: 8494428. DOI: 10.1016/j.clinimag.2020.09.003.


References
1.
Sieber M, Lengsfeld P, Frenzel T, Golfier S, Schmitt-Willich H, Siegmund F . Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions. Eur Radiol. 2008; 18(10):2164-73. DOI: 10.1007/s00330-008-0977-y. View

2.
Orel S, Mendonca M, Reynolds C, SCHNALL M, Solin L, Sullivan D . MR imaging of ductal carcinoma in situ. Radiology. 1997; 202(2):413-20. DOI: 10.1148/radiology.202.2.9015067. View

3.
Jansen S, Conzen S, Fan X, Krausz T, Zamora M, Foxley S . Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation. Phys Med Biol. 2008; 53(19):5481-93. PMC: 4251813. DOI: 10.1088/0031-9155/53/19/014. View

4.
De Stasio G, Rajesh D, Casalbore P, Daniels M, Erhardt R, Frazer B . Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?. Neurol Res. 2005; 27(4):387-98. DOI: 10.1179/016164105X17206. View

5.
Saslow D, Boetes C, Burke W, Harms S, Leach M, Lehman C . American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57(2):75-89. DOI: 10.3322/canjclin.57.2.75. View